{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:52:11Z","timestamp":1793850731954,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Parkinson\u2019s Disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. PD is diagnosed by a combination of motor symptoms including bradykinesia, resting tremors, rigidity and postural instability. Prodromal PD is the stage preceding the onset of classic motor symptoms of PD. The diagnosis of prodromal PD remains challenging despite many available diagnostic modalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This scoping review aims to investigate and explore the current diagnostic modalities used to detect prodromal PD, focusing particularly on multimodal imaging analysis and AI-based approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We adhered to the PRISMA-SR guidelines for scoping reviews. We conducted a comprehensive literature search at multiple databases such as PubMed, Scopus, Web of Science, and the Cochrane Library from inception to July 2024, using keywords related to prodromal PD and diagnostic modalities. We included studies based on predefined inclusion and exclusion criteria and performed data extraction using a standardized form.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The search included 9 studies involving 567 patients with prodromal PD and 35,643 control. Studies utilized various diagnostic approaches including neuroimaging techniques and AI-driven models. sensitivity ranging from 43 to 84% and specificity up to 96%. Neuroimaging and AI technologies showed promising results in identifying early pathological changes and predicting PD onset. The highest specificity was achieved by neuromelanin-sensitive imaging model, while highest sensitivity was achieved by standard 10-s electrocardiogram (ECG)\u2009+\u2009Machine learning model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Advanced diagnostic modalities such as AI-driven models and multimodal neuroimaging revealed promising results in early detection of prodromal PD. However, their clinical application as screening tool for prodromal PD is limited because of the lack of validation. Future research should be directed towards using Multimodal imaging in diagnosing and screening for prodromal PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12880-025-01620-5","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T01:26:31Z","timestamp":1743211591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Multimodal diagnostic tools and advanced data models for detection of prodromal Parkinson\u2019s disease: a scoping review"],"prefix":"10.1186","volume":"25","author":[{"given":"Ibrahim","family":"Serag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Y.","family":"Azzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr K.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab Adel","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Tarek","family":"Hefnawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ahmed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Negida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"3","key":"1620_CR1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","volume":"10","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Arachchige ASPM. Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: A review of the literature. AIMS Neurosci. 2023;10(3):200\u201331.","journal-title":"AIMS Neurosci"},{"key":"1620_CR2","volume-title":"Parkinson\u2019s disease: pathogenesis and clinical aspects","author":"A Kouli","year":"2018","unstructured":"Kouli A, Torsney KM, Kuan W-L. Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: Stoker TB, Greenland JC, editors. Parkinson\u2019s disease: pathogenesis and clinical aspects. Brisbane (AU): Codon. 2018."},{"issue":"Suppl 1","key":"1620_CR3","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/S1353-8020(11)70062-1","volume":"18","author":"GW Ross","year":"2012","unstructured":"Ross GW, Abbott RD, Petrovitch H, Tanner CM, White LR. Pre-motor features of Parkinson\u2019s disease: the Honolulu-Asia aging study experience. Parkinsonism Relat Disord. 2012;18(Suppl 1):S199\u2013202.","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"1620_CR4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/mdc3.13687","volume":"10","author":"N Heng","year":"2023","unstructured":"Heng N, Malek N, Lawton MA, Nodehi A, Pitz V, Grosset KA, et al. Striatal dopamine loss in early Parkinson\u2019s disease: systematic review and novel analysis of dopamine transporter imaging. Mov Disord Clin Pract (Hoboken). 2023;10(4):539\u201346.","journal-title":"Mov Disord Clin Pract (Hoboken)"},{"key":"1620_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","volume":"54","author":"SM Goldman","year":"2014","unstructured":"Goldman SM. Environmental toxins and Parkinson\u2019s disease. Annu Rev Pharmacol Toxicol. 2014;54:141\u201364.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"1620_CR6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41531-022-00410-y","volume":"8","author":"AW Willis","year":"2022","unstructured":"Willis AW, Roberts E, Beck JC, Fiske B, Ross W, Savica R, et al. Incidence of Parkinson disease in North America. Npj Parkinsons Disease. 2022;8(1):170.","journal-title":"Npj Parkinsons Disease"},{"issue":"12","key":"1620_CR7","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, et al. MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord. 2015;30(12):1600\u201311.","journal-title":"Mov Disord"},{"issue":"10","key":"1620_CR8","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1097\/MS9.0000000000001142","volume":"85","author":"P Prajjwal","year":"2023","unstructured":"Prajjwal P, Flores Sanga HS, Acharya K, Tango T, John J, Rodriguez RSC, et al. Parkinson\u2019s disease updates: addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment. Ann Med Surg (Lond). 2023;85(10):4887\u2013902.","journal-title":"Ann Med Surg (Lond)"},{"issue":"5","key":"1620_CR9","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/acn3.51753","volume":"10","author":"LM Chahine","year":"2023","unstructured":"Chahine LM, Beach TG, Adler CH, Hepker M, Kanthasamy A, Appel S, et al. Central and peripheral \u03b1-synuclein in Parkinson disease detected by seed amplification assay. Ann Clin Transl Neurol. 2023;10(5):696\u2013705.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"1620_CR10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41531-024-00730-1","volume":"10","author":"Z Xu","year":"2024","unstructured":"Xu Z, Hu T, Xu C, Liang X, Li S, Sun Y, et al. Disease progression in proposed brain-first and body-first Parkinson\u2019s disease subtypes. Npj Parkinsons Disease. 2024;10(1):111.","journal-title":"Npj Parkinsons Disease"},{"key":"1620_CR11","unstructured":"Parkinson\u2019s Disease. Challenges, Progress, and Promise| National Institute of Neurological Disorders and Stroke. [cited 2024 Jul 27]. Available from: https:\/\/www.ninds.nih.gov\/current-research\/focus-disorders\/parkinsons-disease-research\/parkinsons-disease-challenges-progress-and-promise"},{"key":"1620_CR12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fnagi.2016.00147","volume":"8","author":"S Heinzel","year":"2016","unstructured":"Heinzel S, Roeben B, Ben-Shlomo Y, Lerche S, Alves G, Barone P, et al. Prodromal markers in Parkinson\u2019s disease: limitations in longitudinal studies and lessons learned. Front Aging Neurosci. 2016;8:147.","journal-title":"Front Aging Neurosci"},{"key":"1620_CR13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fneur.2020.00395","volume":"11","author":"E Hustad","year":"2020","unstructured":"Hustad E, Aasly JO. Clinical and imaging markers of prodromal Parkinson\u2019s disease. Front Neurol. 2020;11:395.","journal-title":"Front Neurol"},{"key":"1620_CR14","doi-asserted-by":"crossref","first-page":"645996","DOI":"10.3389\/fnagi.2021.645996","volume":"13","author":"T Du","year":"2021","unstructured":"Du T, Wang L, Liu W, Zhu G, Chen Y, Zhang J. Biomarkers and the role of \u03b1-Synuclein in Parkinson\u2019s disease. Front Aging Neurosci. 2021;13:645996.","journal-title":"Front Aging Neurosci"},{"key":"1620_CR15","doi-asserted-by":"crossref","first-page":"1232387","DOI":"10.3389\/fnagi.2023.1232387","volume":"15","author":"H Jackson","year":"2023","unstructured":"Jackson H, Anzures-Cabrera J, Simuni T, Postuma RB, Marek K, Pagano G. Identifying prodromal symptoms at high specificity for Parkinson\u2019s disease. Front Aging Neurosci. 2023;15:1232387.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1620_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40035-022-00286-1","volume":"11","author":"P Mahlknecht","year":"2022","unstructured":"Mahlknecht P, Marini K, Werkmann M, Poewe W, Seppi K. Prodromal Parkinson\u2019s disease: hype or hope for disease-modification trials? Transl Neurodegener. 2022;11(1):11.","journal-title":"Transl Neurodegener"},{"issue":"4","key":"1620_CR17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/jnc.15516","volume":"159","author":"NSR Bidesi","year":"2021","unstructured":"Bidesi NSR, Vang Andersen I, Windhorst AD, Shalgunov V, Herth MM. The role of neuroimaging in Parkinson\u2019s disease. J Neurochem. 2021;159(4):660\u201389.","journal-title":"J Neurochem"},{"issue":"4","key":"1620_CR18","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.21037\/qims-23-1478","volume":"14","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Wang H, Shi Y, Li W. White matter biomarker for predicting de Novo Parkinson\u2019s disease using tract-based Spatial statistics: a machine learning-based model. Quant Imaging Med Surg. 2024;14(4):3086\u2013106.","journal-title":"Quant Imaging Med Surg"},{"issue":"9","key":"1620_CR19","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00702-022-02498-1","volume":"129","author":"L T\u00f6nges","year":"2022","unstructured":"T\u00f6nges L, Buhmann C, Klebe S, Klucken J, Kwon EH, M\u00fcller T, et al. Blood-based biomarker in Parkinson\u2019s disease: potential for future applications in clinical research and practice. J Neural Transm. 2022;129(9):1201\u201317.","journal-title":"J Neural Transm"},{"key":"1620_CR20","doi-asserted-by":"crossref","unstructured":"Lai H, Li X-Y, Xu F, Zhu J, Li X, Song Y et al. Applications of machine learning to diagnosis of Parkinson\u2019s disease. Brain Sci. 2023;13(11).","DOI":"10.3390\/brainsci13111546"},{"issue":"4","key":"1620_CR21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/electronics12040783","volume":"12","author":"S Dixit","year":"2023","unstructured":"Dixit S, Bohre K, Singh Y, Himeur Y, Mansoor W, Atalla S, et al. A comprehensive review on AI-Enabled models for Parkinson\u2019s disease diagnosis. Electronics. 2023;12(4):783.","journal-title":"Electronics"},{"key":"1620_CR22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.parkreldis.2022.01.003","volume":"95","author":"L Jeancolas","year":"2022","unstructured":"Jeancolas L, Mangone G, Petrovska-Delacr\u00e9taz D, Benali H, Benkelfat B-E, Arnulf I, et al. Voice characteristics from isolated rapid eye movement sleep behavior disorder to early Parkinson\u2019s disease. Parkinsonism Relat Disord. 2022;95:86\u201391.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"1620_CR23","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1038\/s41467-024-49949-9","volume":"15","author":"A Zarkali","year":"2024","unstructured":"Zarkali A, Thomas GEC, Zetterberg H, Weil RS. Neuroimaging and fluid biomarkers in Parkinson\u2019s disease in an era of targeted interventions. Nat Commun. 2024;15(1):5661.","journal-title":"Nat Commun"},{"issue":"7","key":"1620_CR24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"key":"1620_CR25","doi-asserted-by":"crossref","unstructured":"Holtbernd F, Romanzetti S, Oertel WH, Knake S, Sittig E, Heidbreder A et al. Convergent patterns of structural brain changes in rapid eye movement sleep behavior disorder and Parkinson\u2019s disease on behalf of the German rapid eye movement sleep behavior disorder study group. Sleep. 2021;44(3).","DOI":"10.1093\/sleep\/zsaa199"},{"key":"1620_CR26","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3389\/fnins.2018.00967","volume":"12","author":"\u00d3 Pe\u00f1a-Nogales","year":"2018","unstructured":"Pe\u00f1a-Nogales \u00d3, Ellmore TM, de Luis-Garc\u00eda R, Suescun J, Schiess MC, Giancardo L. Longitudinal connectomes as a candidate progression marker for prodromal Parkinson\u2019s disease. Front Neurosci. 2018;12:967.","journal-title":"Front Neurosci"},{"key":"1620_CR27","doi-asserted-by":"crossref","unstructured":"Pyatigorskaya N, Gaurav R, Arnaldi D, Leu-Semenescu S, Yahia-Cherif L, Valabregue R et al. Magnetic resonance imaging biomarkers to assess substantia Nigra damage in idiopathic rapid eye movement sleep behavior disorder. Sleep. 2017;40(11).","DOI":"10.1093\/sleep\/zsx149"},{"issue":"1","key":"1620_CR28","doi-asserted-by":"crossref","first-page":"11319","DOI":"10.1038\/s41598-020-68241-6","volume":"10","author":"O Akbilgic","year":"2020","unstructured":"Akbilgic O, Kamaleswaran R, Mohammed A, Ross GW, Masaki K, Petrovitch H, et al. Electrocardiographic changes predate Parkinson\u2019s disease onset. Sci Rep. 2020;10(1):11319.","journal-title":"Sci Rep"},{"issue":"1","key":"1620_CR29","doi-asserted-by":"crossref","first-page":"12290","DOI":"10.1038\/s41598-023-38782-7","volume":"13","author":"I Karabayir","year":"2023","unstructured":"Karabayir I, Gunturkun F, Butler L, Goldman SM, Kamaleswaran R, Davis RL, et al. Externally validated deep learning model to identify prodromal Parkinson\u2019s disease from electrocardiogram. Sci Rep. 2023;13(1):12290.","journal-title":"Sci Rep"},{"issue":"16","key":"1620_CR30","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1002\/hbm.26066","volume":"43","author":"C Ran","year":"2022","unstructured":"Ran C, Yang Y, Ye C, Lv H, Ma T. Brain age vector: A measure of brain aging with enhanced neurodegenerative disorder specificity. Hum Brain Mapp. 2022;43(16):5017\u201331.","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"1620_CR31","doi-asserted-by":"crossref","first-page":"e0280609","DOI":"10.1371\/journal.pone.0280609","volume":"18","author":"M Sood","year":"2023","unstructured":"Sood M, Suenkel U, von Thaler A-K, Zacharias HU, Brockmann K, Eschweiler GW, et al. Bayesian network modeling of risk and prodromal markers of Parkinson\u2019s disease. PLoS ONE. 2023;18(2):e0280609.","journal-title":"PLoS ONE"},{"issue":"8","key":"1620_CR32","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1038\/s41591-023-02440-2","volume":"29","author":"A-K Schalkamp","year":"2023","unstructured":"Schalkamp A-K, Peall KJ, Harrison NA, Sandor C. Wearable movement-tracking data identify Parkinson\u2019s disease years before clinical diagnosis. Nat Med. 2023;29(8):2048\u201356.","journal-title":"Nat Med"},{"issue":"1","key":"1620_CR33","doi-asserted-by":"crossref","first-page":"e14480","DOI":"10.1111\/cns.14480","volume":"30","author":"L Zhang","year":"2024","unstructured":"Zhang L, Zhang P, Dong Q, Zhao Z, Zheng W, Zhang J, et al. Fine-grained features characterize hippocampal and amygdaloid change pattern in Parkinson\u2019s disease and discriminate cognitive-deficit subtype. CNS Neurosci Ther. 2024;30(1):e14480.","journal-title":"CNS Neurosci Ther"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01620-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01620-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01620-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T01:27:42Z","timestamp":1743211662000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01620-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1620"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01620-5","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"19 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}